Tarsus Pharmaceuticals, Inc.
Price Action
Technical Summary
WEAKENINGTarsus Pharmaceuticals, Inc. is in a technical downtrend, trading below key resistance levels with a broken trend structure. Relative strength is weak (RS Rating: 33), showing significant lag compared to the market leaders. Earnings growth of 75% provides fundamental context to the price action. A decisive close above the 200-day moving average is required to signal a potential trend reversal.
Trend Template (Minervini)
Price vs Moving Averages
| Period | Value | Spread | Signal |
|---|---|---|---|
| 20 SMA | $65.99 | -1.87% | BELOW |
| 50 SMA | $68.60 | -5.60% | BELOW |
| 100 SMA | $70.66 | -8.35% | BELOW |
| 150 SMA | $71.41 | -9.32% | BELOW |
| 200 SMA | $66.45 | -2.54% | BELOW |
Price Performance
Technical Indicators
Risk Profile
Volume Analysis
Earnings Momentum
Growth Trends
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
Key Metrics
Frequently Asked Questions
Is TARS in an uptrend right now?
TARS has a trend score of 1/4 based on Minervini's Stage Analysis. Currently showing broken structure - 1 of 4 trend criteria are met.
Is TARS overbought or oversold?
TARS's RSI (14) is 47. The stock is in neutral territory, neither overbought nor oversold.
Is TARS outperforming the market?
TARS has a Relative Strength (RS) Rating of 33 out of 99. TARS is currently lagging the broader market.
Where is TARS in its 52-week range?
TARS is trading at $64.76, which is 76% of its 52-week high ($85.25) and 56% above its 52-week low ($38.51).
How volatile is TARS?
TARS has a Beta of 0.65 and 52-week volatility of 44%. It's less volatile than the S&P 500 - generally more stable.